Logo image
Association between parenteral nutrition containing intravenous lipid emulsions and bloodstream infections in patients with single-lumen central venous access: A secondary analysis of a randomized trial
Journal article   Open access   Peer reviewed

Association between parenteral nutrition containing intravenous lipid emulsions and bloodstream infections in patients with single-lumen central venous access: A secondary analysis of a randomized trial

Nicole C Gavin, Emily Larsen, Naomi Runnegar, Gabor Mihala, Samantha Keogh, David McMillan, Gillian Ray-Barruel and Claire M Rickard
Journal of Parenteral and Enteral Nutrition, Vol.47(6), pp.783-795
2023
PMCID: PMC10946626
PMID: 37288612
pdf
Association between parenteral nutrition containing intravenous lipid emulsions and bloodstream infections in patients with single-lumen central venous access - A secondary analysis of a randomized trial322.13 kBDownloadView
Accepted Version Open Access
url
https://doi.org/10.1002/jpen.2530View
Published Version

Abstract

Administration Intravenous Catheterization Central Venous Catheter-Related Infections Central Venous Catheters Clinical Nursing Research Fat Emulsion mucosal barrier injury laboratory-confirmed bloodstream infection Parenteral nutrition < Nutrition Vascular Access Devices
Background: Distinguishing primary bloodstream infections (BSIs) related to central venous access devices (CVADs) from those that occur through other mechanisms, such as a damaged mucosal barrier, is difficult. Methods: Secondary analysis was conducted on data from patients with CVADs, collected for a large, randomized trial. Patients were divided into two groups: those who received parenteral nutrition (PN) containing intravenous lipid emulsion (ILE) and those who did not have PN containing ILE. This study investigated the influence of PN containing ILE (ILE PN) on primary BSIs in patients with a CVAD. Results: Of the 807 patients, 180 (22%) received ILE PN. Most (627/807; 73%) were recruited from the hematology and hematopoietic stem cell transplant unit, followed by surgical (90/807; 11%), trauma and burns (61/807; 8%), medical (44/807; 5%), and oncology (23/807; 3%). When primary BSI was differentiated as a central line-associated bloodstream infection (CLABSI) or mucosal barrier injury laboratory-confirmed bloodstream infection (MBI-LCBI), the incidence of CLABSI was similar in the ILE PN and non-ILE PN groups (15/180; 8% vs. 57/627; 9%, p=0.88) and the incidence of MBI-LCBI was significantly different between groups (31/180; 17% ILE PN vs. 41/627; 7% non-ILE PN, p<0.01). Conclusion: Our data indicates that twice as many primary BSIs in ILE PN patients are due to mucosal barrier injuries than CVADs. It is important to consider the MBI-LCBI classification, as some CLABSI prevention efforts aimed at CVADs for the ILE PN population may be better directed to gastrointestinal tract protection interventions.

Details

Metrics

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
Web Of Science research areas
Nutrition & Dietetics

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: SDGs from InCites

Logo image